Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6190495 | Cancer Treatment Reviews | 2014 | 9 Pages |
Abstract
The use of anti-EGFR mAbs is associated with a significantly higher risk of high-grade infection and febrile neutropenia.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Tomohiro Funakoshi, Maya Suzuki, Kazuo Tamura,